Zeus Scientific Inc Listed by avoslocker Ransomware Group: Ransomware Claim — What’s Alleged & What To Do

On December 26, 2022, Zeus Scientific Inc was listed by the AvosLocker ransomware group, which claimed to have exfiltrated internal files from the company’s servers. Public detail remains limited: the number of people affected is unknown, and the full scope of the incident has not been independently confirmed. What is known is that the group asserted it had taken internal material, including NDA contracts, and had begun publishing a first portion of those files.

For an organisation that manufactures clinical diagnostic solutions used in autoimmune and infectious disease testing, any confirmed exposure of internal systems carries weight. Patients, partners, and employees may reasonably want to understand what has been reported and what remains unverified.

Breaking down the breach

According to the available record, Zeus Scientific Inc appeared on AvosLocker’s listings on December 26, 2022. The group described the incident as a ransomware attack in which internal files were allegedly exfiltrated from Zeus Scientific servers. It further claimed to have published the first part of that material, citing items such as NDA contracts among the content.

No public figure has been given for the number of individuals affected. The precise method of initial access, the duration of any intrusion, and whether encryption was also deployed on production systems are not detailed in the reported facts. The listing itself constitutes a claim by the threat actor; independent confirmation of the full contents or the completeness of the alleged publication is not part of the public record summarised here.

Who is avoslocker?

AvosLocker is a ransomware operation that has been active in recent years, typically following a double-extortion model: encrypting systems while also copying data and threatening to publish it if demands are not met. The group has historically operated a leak site on which it names victims and, in some cases, releases samples or larger archives of stolen files. Like other ransomware crews of this type, it has targeted organisations across multiple sectors rather than specialising in a single industry.

Public reporting on AvosLocker has associated the name with affiliates who gain access, move laterally, and exfiltrate data before ransomware deployment. Specific technical claims about how this particular intrusion at Zeus Scientific was carried out are not provided in the facts; only the group’s assertion that it obtained and began releasing internal files is on record. Statements that appear on a ransomware leak site should be treated as unverified claims unless corroborated by the victim or by independent investigation.

Who is Zeus Scientific Inc?

Zeus Scientific, Inc. manufactures clinical diagnostic solutions, with a focus on flexible offerings for autoimmune and infectious disease testing. Organisations in this sector typically develop, produce, and support laboratory assays and related instrumentation used by clinical laboratories and healthcare providers. Their work sits at the intersection of medical device manufacturing, laboratory medicine, and regulated quality systems.

A breach affecting such a company is consequential because internal systems may hold proprietary product information, commercial contracts, quality and regulatory documentation, and correspondence with partners or customers. Even when patient clinical results are not the primary data store, the surrounding business and operational records can still expose sensitive commercial and personal information. The company’s public profile as a diagnostics manufacturer means that partners and counterparties may also have an interest in understanding whether shared materials were among any exfiltrated files.

The information in question

The facts state that internal files were exfiltrated in a ransomware attack and that AvosLocker claimed to publish a first portion of material from Zeus Scientific servers, including NDA contracts and similar documents. Beyond that description, the exact inventory of exposed data types has not been fully itemised in the public summary.

Organisations of this kind commonly hold employee records, vendor and customer contracts, non-disclosure and commercial agreements, product and quality documentation, and internal operational files. Whether any of those categories—apart from the NDA contracts explicitly mentioned in the actor’s claim—were included remains unconfirmed. No count of records, file volumes, or named individuals has been provided. Readers should treat the precise contents as undisclosed except where the group’s own listing language is quoted as a claim.

What's at stake

For people whose information may have been among internal files, risks include unwanted contact, social engineering that references real contracts or workplace details, and longer-term misuse of personal or professional data if it later circulates more widely. Employees, contractors, and counterparties named in NDAs or related documents can face targeted phishing that appears legitimate because it draws on genuine context.

For the organisation, stakes include operational disruption, potential regulatory and contractual notification duties, erosion of partner trust, and the cost of investigation and remediation. In diagnostics manufacturing, integrity of quality systems and confidentiality of commercial arrangements matter to customers and regulators alike. None of these outcomes is asserted here as having already materialised at a specific scale; they are the concrete categories of harm that typically follow confirmed exfiltration of internal corporate files.

Were you affected?

If you have a past or present relationship with Zeus Scientific Inc—as an employee, contractor, partner, or counterpart to an NDA—consider practical steps: monitor accounts and communications for unusual activity, be cautious of unsolicited messages that reference the company or specific agreements, and review any official notices the company may issue. Because the number of people affected and the full data inventory remain unknown, individual exposure cannot be confirmed from public facts alone.

You can also run a free exposure scan of your email address to check whether your information has already surfaced in known breach datasets. That step does not prove or disprove involvement in this specific incident, but it can help you see whether your credentials or personal details appear in broader collections of leaked data and decide whether further monitoring or password changes are warranted.

AICompiled with AI assistance from public sources and published under our editorial standards.